'Indian IP and liabilities law barrier to pharma R & D investment'

India's intellectual property regulations and liabilities laws pose a major barrier to foreign companies, specially from the US, that prevents them from increasing their footprint in the country's huge market, pharma sector leaders have said.
Source: The Economic Times Healthcare and Biotech News - Category: Pharmaceuticals Source Type: news